
-
'Remember Charlie Hebdo!' Protesters seethe at Istanbul magazine
-
Top seed Sinner eases into Wimbledon second round
-
Stocks retreat as profit-taking follows Wall Street records
-
Israel expands campaign in Gaza ahead of Netanyahu's US visit
-
Barcelona's Ansu Fati aims to kick-start career in Monaco
-
Bordeaux-Begles drawn with Northampton in Champions Cup final repeat
-
Sean Combs trial: jurors seek verdict for a second day
-
Trump says will 'take a look' at deporting Musk
-
Greece starts charging tourist tax on cruises
-
Trump heads for 'Alligator Alcatraz' migrant detention center
-
US Senate push to pass Trump's unpopular spending bill enters second day
-
England captain Stokes relishing Pant battle in India series
-
Ukraine hits Russian city deep behind front line, leaves three dead
-
Hinault backs 'complete rider' Pogacar for Tour de France glory
-
Third seed Pegula suffers shock Wimbledon exit
-
Stocks struggle tracking US trade deal prospects
-
Djokovic launches Grand Slam history bid at Wimbledon
-
UK arrests three in Lucy Letby hospital probe
-
Europe on high alert as surprise early heatwave creeps north
-
UK govt faces major rebellion in welfare vote
-
Indian capital bans fuel for old cars in anti-pollution bid
-
Flintoff rules himself out of top England coaching job
-
Russia ramps up drone strikes on Ukraine in June: AFP analysis
-
Japan had hottest June on record: weather agency
-
Asian stocks rise on trade deal hopes, Tokyo hit by Trump warning
-
Thailand's PM suspended by Constitutional Court
-
Blur will return to musical oasis, says drummer Rowntree
-
CBEX crypto scam: AI-hyped Ponzi scheme defrauds African investors
-
Inzaghi hails 'extraordinary' Al Hilal after City upset
-
Man City, Inter Milan crash out of Club World Cup in last 16
-
North Korea's Kim shown honouring troops killed in Russia-Ukraine war
-
Saudi's Al Hilal knock Man City out of Club World Cup in huge shock
-
'In our blood': Egyptian women reclaim belly dance from stigma
-
Online memorial for children dead in Hiroshima, Nagasaki
-
US Senate in final push to pass Trump spending bill
-
Asian stocks rise on trade deal hopes, Tokyo hit by tariff warning
-
Hong Kong rights record under fire as it marks China handover anniversary
-
Bangladeshis cling to protest dreams a year after revolution
-
Djokovic, Sinner enter Wimbledon fray
-
European security tops Denmark's EU presidency priorities
-
France expecting peak temperatures as heatwave hits Europe
-
Germany eye return to women's football summit at Euro 2025
-
'Every day I see land disappear': Suriname's battle to keep sea at bay
-
England feel pressure to perform at Euros as stars pull out
-
Clashes in Istanbul over alleged 'Prophet Mohammed' cartoon
-
India face 'last-minute' Bumrah call as they bid to level England series
-
Dortmund up against 'superstar' Ramos, aggressive Monterrey: Kovac
-
US judge orders Argentina to sell 51% stake in oil firm YPF
-
RETRANSMISSION: Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
-
New Horizon Medical Solutions Adds AmchoPlast(TM) to its Industry-Best Product Portfolio

The abortion pill at the center of a US court battle
The US Supreme Court has weighed in on the legal battle over an abortion pill that accounts for more than half of the abortions in the United States, freezing restrictions imposed on the drug by an appeals court.
Here is background on the drug, mifepristone, and its use:
- How widespread is abortion pill use? -
According to the Guttmacher Institute, the pill accounted for more than half -- 53 percent -- of the 930,160 abortions documented by the reproductive health research and policy organization in the United States in 2020.
That was up from 17 percent in 2008 and 39 percent in 2017.
While the number of so-called medication abortions has gone up dramatically in the United States in recent years, it is still not as prevalent as in several European nations.
In France, for example, medication abortions represented 70 percent of the total number of abortions in 2020.
- How does it work? -
The abortion pill is different from the "morning after" pill, which is taken by a woman after sexual intercourse to prevent becoming pregnant.
The abortion pill is taken to induce an abortion once a woman confirms that she is pregnant.
The process in fact involves more than one pill. The first, mifepristone, also known as RU 486, stops a pregnancy from proceeding normally by blocking production of the hormone progesterone.
Another drug, misoprostol, is taken up to 48 hours later and causes cramps, bleeding and the emptying of the uterus.
Abortion pills can be used at home and a medical setting is not required.
- When was the abortion pill approved? -
The US Food and Drug Administration (FDA) gave the green light to mifepristone and misoprostol in 2000 for use up to seven weeks of pregnancy.
It was later approved for use up to 10 weeks of pregnancy, after which a woman would need to undergo an abortion through other means, such as vacuum aspiration.
A group opposed to abortions has challenged the FDA's approvals of mifepristone in federal court in Texas.
The average cost of a medication abortion at Planned Parenthood is $580 but it can cost up to $800.
- Is it safe and effective? -
Use of the abortion pill during the specified time period is considered to be safe and effective by medical experts.
Pregnancies are successfully terminated in more than 95 percent of cases where the pill is used, according to studies.
Serious complications -- excessive bleeding, fever, infection or allergic reaction -- which require a medical consult, are rare.
The abortion pill does not work for ectopic pregnancies, which account for around two percent of all pregnancies and where a fertilized egg grows outside the uterus.
- Where is the pill available? -
At least 13 US states have banned most abortions, including medication abortions, since the Supreme Court's ruling in June 2022 overturning the constitutional right to an abortion.
Despite the bans, a number of organizations have mobilized to provide abortion pills to women in states where abortion is restricted.
The extent of their efforts is difficult to evaluate.
In the states where abortion is legal, the FDA recently loosened restrictions surrounding mifepristone, allowing it to be sent through the mail with a prescription or to be sold directly in pharmacies like any other drug.
A.Mahlangu--AMWN